verapamil has been researched along with Carcinoma 256, Walker in 4 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Carcinoma 256, Walker: A transplantable carcinoma of the rat that originally appeared spontaneously in the mammary gland of a pregnant albino rat, and which now resembles a carcinoma in young transplants and a sarcoma in older transplants. (Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "nifedipine) classes were evaluated for effects on the tumor cell/platelet interactions using Walker 256 carcinosarcoma cells (W256 cells)." | 1.28 | Calcium channel blocker treatment of tumor cells induces alterations in the cytoskeleton, mobility of the integrin alpha IIb beta 3 and tumor-cell-induced platelet aggregation. ( Chopra, H; Fligiel, SE; Hatfield, JS; Honn, KV; Onoda, JM; Rong, X; Taylor, JD; Timar, J, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyazaki, M | 2 |
| Shimoda, T | 2 |
| Itoh, H | 1 |
| Kaiho, T | 1 |
| Iinuma, K | 1 |
| Koyama, T | 1 |
| Nakagawa, K | 1 |
| Andoh, K | 1 |
| Anbiru, S | 1 |
| Ohtawa, S | 1 |
| Timar, J | 1 |
| Chopra, H | 1 |
| Rong, X | 1 |
| Hatfield, JS | 1 |
| Fligiel, SE | 1 |
| Onoda, JM | 1 |
| Taylor, JD | 1 |
| Honn, KV | 1 |
| Utagawa, I | 1 |
| Koshikawa, H | 1 |
| Ito, H | 1 |
| Okui, K | 1 |
| Villani, F | 1 |
| Formelli, F | 1 |
| Monti, E | 1 |
| Piccinini, F | 1 |
| Favalli, L | 1 |
| Rozza, A | 1 |
| Lanza, E | 1 |
| Poggi, P | 1 |
4 other studies available for verapamil and Carcinoma 256, Walker
| Article | Year |
|---|---|
Enhancement of cytotoxicity of doxorubicin by verapamil in the hepatic artery infusion for liver tumors in rats.
Topics: Animals; Carcinoma 256, Walker; Doxorubicin; Hepatic Artery; Infusions, Intra-Arterial; Injections, | 1993 |
Calcium channel blocker treatment of tumor cells induces alterations in the cytoskeleton, mobility of the integrin alpha IIb beta 3 and tumor-cell-induced platelet aggregation.
Topics: Animals; Calcium Channel Blockers; Carcinoma 256, Walker; Cytoskeleton; Diltiazem; Epitopes; Female; | 1992 |
[Enhancement of anti-tumor effect of adriamycin by verapamil in a intrahepatic arterial infusion in the rats].
Topics: Animals; Carcinoma 256, Walker; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Drug | 1992 |
Influence of calcium antagonists on the antitumor activity and the cardiac toxicity of doxorubicin in the rat.
Topics: Animals; Carcinoma 256, Walker; Doxorubicin; Female; Flunarizine; Heart; Myocardium; Rats; Rats, Inb | 1987 |